doi: 10.1097/00002030-200307040-00022.
Selection of resistance mutations in pregnant women receiving zidovudine and lamivudine to prevent HIV perinatal transmission
Affiliations
- PMID: 12824800
- DOI: 10.1097/00002030-200307040-00022
Item in Clipboard
Selection of resistance mutations in pregnant women receiving zidovudine and lamivudine to prevent HIV perinatal transmission
AIDS.
.
Abstract
Two zidovudine/lamivudine regimens for the prevention of HIV perinatal transmission were studied for the selection of resistance mutations. The M184V mutation was detected one week after delivery in six out of fifty women (12%) who received the regimen prepartum, intrapartum and postpartum, and was no longer present 3 months later. No nucleoside reverse transcriptase inhibitor resistance-associated mutations were detected in 50 women who received zidovudine/lamivudine intrapartum and postpartum only. No association with the risk of perinatal transmission was found.
Similar articles
-
Antiretroviral therapy for prevention of mother-to-child HIV transmission : focus on single-dose nevirapine.Clin Drug Investig. 2006;26(11):611-27. doi: 10.2165/00044011-200626110-00001. Clin Drug Investig. 2006. PMID: 17163296 Review.
-
Postpartum antiretroviral drug resistance in HIV-1-infected women receiving pregnancy-limited antiretroviral therapy.AIDS. 2010 Jan 2;24(1):45-53. doi: 10.1097/QAD.0b013e32832e5303. AIDS. 2010. PMID: 19915448 Free PMC article.
-
Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1.JAMA. 2001 Apr 25;285(16):2083-93. doi: 10.1001/jama.285.16.2083. JAMA. 2001. PMID: 11311097 Clinical Trial.
-
Diminished selection for thymidine-analog mutations associated with the presence of M184V in Ethiopian children infected with HIV subtype C receiving lamivudine-containing therapy.Pediatr Infect Dis J. 2006 Nov;25(11):1049-56. doi: 10.1097/01.inf.0000243211.36690.d5. Pediatr Infect Dis J. 2006. PMID: 17072129
-
Antiretroviral prophylaxis of perinatal HIV-1 transmission and the potential impact of antiretroviral resistance.J Acquir Immune Defic Syndr. 2002 Jun 1;30(2):216-29. doi: 10.1097/00042560-200206010-00011. J Acquir Immune Defic Syndr. 2002. PMID: 12045685 Review.
Cited by
-
Nucleoside and nucleotide reverse transcriptase inhibitors in children.Clin Drug Investig. 2007;27(8):509-31. doi: 10.2165/00044011-200727080-00001. Clin Drug Investig. 2007. PMID: 17638393 Review.
-
Antiretroviral therapy for prevention of mother-to-child HIV transmission : focus on single-dose nevirapine.Clin Drug Investig. 2006;26(11):611-27. doi: 10.2165/00044011-200626110-00001. Clin Drug Investig. 2006. PMID: 17163296 Review.
-
Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.Cochrane Database Syst Rev. 2010 Mar 17;2010(3):CD008440. doi: 10.1002/14651858.CD008440. Cochrane Database Syst Rev. 2010. PMID: 20238370 Free PMC article.
-
Field efficacy of zidovudine, lamivudine and single-dose nevirapine to prevent peripartum HIV transmission.AIDS. 2005 Feb 18;19(3):309-18. AIDS. 2005. PMID: 15718842 Free PMC article.
-
Antiretroviral resistance among HIV type 1-infected women first exposed to antiretrovirals during pregnancy: plasma versus PBMCs.AIDS Res Hum Retroviruses. 2008 Jun;24(6):797-804. doi: 10.1089/aid.2007.0246. AIDS Res Hum Retroviruses. 2008. PMID: 18507526 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
